
Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy | Targeted and Immune Therapy | JAMA Oncology | JAMA Network jamanetwork.com/journals/jam…

Diagnostic and interventional abdominal radiologist

Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy | Targeted and Immune Therapy | JAMA Oncology | JAMA Network jamanetwork.com/journals/jam…

🚨EASL CPG on the management of HCC in @JHepatology Major update! ✅ LI-RADS endorsed ✅ Refined treatment algo ✅ More evidence supporting locoregional treatments ✅ Up-to-date discussions 👉bit.ly/3VKZmcy

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉bit.ly/3VKZmcy #CPGs #LiverTwitter @EASLnews @EASLedu @AleksanderKrag

🔥off the press: Tumor burden with AFP improves survival prediction for TACE treated patients with HCC @JHEP_Reports doi.org/10.1016/j.jhepr.2024… 🔎 International observational study 👉Easy to use tool to predict outcome @myESMO @EASLedu @ILCAnews

❕Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study 🔓#OpenAccess at👉jhep-reports.eu/article/S258… #LiverTwitter #HCC @NaultJc

Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment - The Lancet Oncology thelancet.com/journals/lanon…

🩺MRI-assessed intratumoral fat was generally nonprognostic; however, homogeneous intratumoral fat correlated with longer recurrence-free and overall survival in an Asian cohort of hepatocellular carcinoma patients. Findings from @maximeronot! pubs.rsna.org/doi/10.1148/ra…

Risk of HCC in Subcentimeter Liver Nodules Identified on Surveillance Ultrasound @AGA_CGH doi.org/10.1016/j.cgh.2024.0… 🔎 Systematic Review, 9 studies, 888 pts 👉risk of HCC: 21.3% 👉risk factors: older age, male sex, elevated AFP, low plts, CP B 🧐repeat ultrasound in 3-6 mo reasonable @myESMO @EASLnews @ILCAnews #livertwitter

Read 'open access' at bit.ly/3AdVol6 "Early-Life Infections, Antibiotics and Later Risk of Childhood and Early Adult-Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts" by Mårild et al #GItwitter #IBD

💥EXPERT OPINION Integration of new technologies in the multidisciplinary approach to primary liver tumours ➡️The next-generation tumour board Full text here👉journal-of-hepatology.eu/art… @Naultjc #LiverTwitter

🔥off the press Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC @JHEP_Reports 🔎🗺️RWD study ❓how to best select for TACE > AFP & Tumor burden 🧐helpful for the discussion in the tumor board 👇my author link: doi.org/10.1016/j.jhepr.2024… @myESMO @EASLedu @ILCAnews #livertwitter

The position paper from EASL about "management of rare primary liver cancers" was recently published in Journal Of Hepatology @EASLnews @JHepatology @campani_claudia @Zucmanrossi @ma5RN journal-of-hepatology.eu/art…

Updated data for atezo + bev vs surveillance in resected or ablated high risk HCC #ESMO24 🔎IMbrave050 👉RFS 33.2 vs 36 mo, HR 0.9 👉OS: HR: 1.26 🧐Benefit not sustained! Disappointing.. 🧐Caveat of (too) early read outs… @myESMO #ESMOAmbassadors @ILCA @EASLedu


Congratulations to @F_matteini and team @marco_dioguardi @maximeronot @DrF_Vernuccio for the article "Discontinuous peripheral enhancement of focal liver lesions on CT and MRI: outside the box of typical cavernous hemangioma" published in @Abdominal_Rad 🔗doi.org/10.1007/s00261-024-0…

🚨 A new episode of the @radiology_rsna podcast is now available! 🚨 @LindaChuMD speaks with Dr. Lorenzo Garzelli and @maximeronot about Predictors of Intestinal Resection–Free Survival after Endovascular Revascularization #RadPodcasts bit.ly/4f9mrh2
